Charles River Laboratories | Aktuelle Verpflichtungen

Aktienkurs
161.03
Täglich Wechseln
-7.89 -4.67%
Monatlich
-28.99%
Jährlich
-1.22%
Q1 Prognose
163.68




Aktuelle Verpflichtungen Veränderung Datum
Agilent USD 2.35B 455M 2025-09
Align Technology USD 1.92B 46.45M 2025-12
Bio-Rad Laboratories USD 517M 5.3M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Cardinal Health USD 43.31B 3.05B 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Cigna USD 56.45B 326M 2025-09
Concord Medical Services Hldg CNY 1.34B 214.68M 2023-06
CVS Health USD 88.69B 4B 2025-12
Danaher USD 6.81B 483M 2025-12
Dentsply International USD 1.4B 239M 2025-09
Elevance Health USD 41.04B 157M 2025-12
Galapagos EUR 366.56M 36.39M 2025-09
Hologic USD 951.3M 25.9M 2025-12
Humana USD 16.35B 166M 2025-12
Illumina USD 1.59B 377M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Intrexon USD 23.02M 38K 2024-06
IQVIA Holdings USD 8.34B 170M 2025-12
Laboratory Of America USD 2.82B 194.3M 2025-12
Lonza CHF 3.58B 970M 2024-12
McKesson USD 68.13B 100M 2025-12
Merck EUR 8.64B 1.22B 2025-09
Mettler Toledo International USD 1.2B 5.99M 2025-12
Novartis USD 32B 286M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Quest Diagnostics USD 2.28B 144M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Thermo Fisher Scientific USD 15.19B 301M 2025-12
United Therapeutics USD 546.3M 19.2M 2025-09
UnitedHealth USD 115.53B 4.74B 2025-09
Veradigm USD 253.09M 3.24M 2022-09
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 654.9M 19.5M 2025-12


Charles River Laboratories Aktuelle Verpflichtungen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.